BioXcel Therapeutics Inc. held annual shareholder meeting
I'm PortAI, I can summarize articles.
BioXcel Therapeutics Inc. held its annual shareholder meeting on December 12, 2025. Three board nominees were elected, Ernst & Young LLP was ratified as the independent auditor for 2025, and a potential reverse stock split was authorized. Additionally, authorization for possible meeting adjournments to solicit more proxies was granted.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments